2017

1. Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study

   Transplant International, Vol. 30, Núm. 10, pp. 1041-1050